Cargando…
Plasma GBP2 promoter methylation is associated with advanced stages in breast cancer
Blood methylated cell-free DNA (cfDNA) as a minimally invasive cancer biomarker has great importance in cancer management. Guanylate binding protein 2 (GBP2) has been considered as a possible controlling factor in tumor development. GBP2 gene expression and its promoter methylation status in both pl...
Autores principales: | Rahvar, Farzaneh, Salimi, Mahdieh, Mozdarani, Hossein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Genética
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783727/ https://www.ncbi.nlm.nih.gov/pubmed/33211060 http://dx.doi.org/10.1590/1678-4685-GMB-2019-0230 |
Ejemplares similares
-
Methylation in the promoter regions of WT1, NKX6-1 and
DBC1 genes in cervical cancer tissues of Uygur women in
Xinjiang
por: Wu, Dan, et al.
Publicado: (2018) -
Association of GNB3 C825T polymorphism with plasma electrolyte balance and susceptibility to hypertension
por: Nejatizadeh, Azim, et al.
Publicado: (2011) -
Gender-specific association of the rs6499640 polymorphism in the
FTO gene with plasma lipid levels in Chinese
children
por: Gao, Liwang, et al.
Publicado: (2018) -
Association of FOSL1 copy number alteration and
triple negative breast tumors
por: Serino, Leandro Tamião Rodrigues, et al.
Publicado: (2019) -
Mitochondrial DNA common deletion is not associated with thyroid, breast and colorectal tumors in Turkish patients
por: Aral, Cenk, et al.
Publicado: (2010)